272 related articles for article (PubMed ID: 25723616)
1. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission.
Jones PD; Kappelman MD; Martin CF; Chen W; Sandler RS; Long MD
Inflamm Bowel Dis; 2015 May; 21(5):1063-71. PubMed ID: 25723616
[TBL] [Abstract][Full Text] [Related]
2. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
J Clin Gastroenterol; 2016 Feb; 50(2):152-6. PubMed ID: 26485106
[TBL] [Abstract][Full Text] [Related]
3. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
[TBL] [Abstract][Full Text] [Related]
4. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
5. Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.
Weaver KN; Kappelman MD; Sandler RS; Martin CF; Chen W; Anton K; Long MD
Inflamm Bowel Dis; 2016 Nov; 22(11):2672-2677. PubMed ID: 27755268
[TBL] [Abstract][Full Text] [Related]
6. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.
Long MD; Kappelman MD; Martin CF; Lewis JD; Mayer L; Kinneer PM; Sandler RS
Inflamm Bowel Dis; 2012 Nov; 18(11):2099-106. PubMed ID: 22287300
[TBL] [Abstract][Full Text] [Related]
7. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
8. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
9. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
[TBL] [Abstract][Full Text] [Related]
10. Mucosal Healing in Clinical Practice: A Single-Center Pediatric IBD Experience.
Santha SL; Shankar PR; Pan A; Schoen B; Kugathasan S; Sauer CG
Inflamm Bowel Dis; 2017 Aug; 23(8):1447-1453. PubMed ID: 28644180
[TBL] [Abstract][Full Text] [Related]
11. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort.
Romberg-Camps MJ; Bol Y; Dagnelie PC; Hesselink-van de Kruijs MA; Kester AD; Engels LG; van Deursen C; Hameeteman WH; Pierik M; Wolters F; Russel MG; Stockbrügger RW
Inflamm Bowel Dis; 2010 Dec; 16(12):2137-47. PubMed ID: 20848468
[TBL] [Abstract][Full Text] [Related]
12. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
Gecse KB; Lovász BD; Farkas K; Banai J; Bene L; Gasztonyi B; Golovics PA; Kristóf T; Lakatos L; Csontos ÁA; Juhász M; Nagy F; Palatka K; Papp M; Patai Á; Lakner L; Salamon Á; Szamosi T; Szepes Z; Tóth GT; Vincze Á; Szalay B; Molnár T; Lakatos PL
J Crohns Colitis; 2016 Feb; 10(2):133-40. PubMed ID: 26661272
[TBL] [Abstract][Full Text] [Related]
14. Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.
Roblin X; Marotte H; Rinaudo M; Del Tedesco E; Moreau A; Phelip JM; Genin C; Peyrin-Biroulet L; Paul S
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):80-84.e2. PubMed ID: 23891927
[TBL] [Abstract][Full Text] [Related]
15. De novo Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis and Inflammatory Bowel Disease Unclassified: Long-Term Follow-Up of a Prospective Inflammatory Bowel Disease Registry.
Zaghiyan K; Kamiński JP; Barmparas G; Fleshner P
Am Surg; 2016 Oct; 82(10):977-981. PubMed ID: 27779987
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.
Molander P; Färkkilä M; Kemppainen H; Blomster T; Jussila A; Mustonen H; Sipponen T
Scand J Gastroenterol; 2017 Mar; 52(3):284-290. PubMed ID: 27806638
[TBL] [Abstract][Full Text] [Related]
17. High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.
Barnes EL; Long MD; Kappelman MD; Martin CF; Sandler RS
Inflamm Bowel Dis; 2019 Jun; 25(7):1248-1254. PubMed ID: 30590700
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
19. Avoidance of Fiber Is Associated With Greater Risk of Crohn's Disease Flare in a 6-Month Period.
Brotherton CS; Martin CA; Long MD; Kappelman MD; Sandler RS
Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1130-6. PubMed ID: 26748217
[TBL] [Abstract][Full Text] [Related]
20. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
